About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
IMGN - ImmunoGen| Previous Close | $7.65 | Open | $7.48 |
| Volume | 1.7M | Market Cap | 1.505B |
| Yield | Last Dividend |
| ImmunoGen Announces Webcasts of Presenta... | 11/18/20 |
| WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Webcasts of Presentations at Upcoming Virtual Conferences | |
| H.C. Wainwright Stick to Their Buy Ratin... | 11/09/20 |
| H.C. Wainwright Stick to Their Buy Rating for Immunogen | |
| Immunogen Inc (IMGN) Q3 2020 Earnings Ca... | 11/08/20 |
| Immunogen Inc (NASDAQ: IMGN) Q3 2020 earnings call dated Nov. 06, 2020 | |
| ImmunoGen Will stock surge before Earnin... | 11/06/20 |
| ImmunoGen announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| ImmunoGen EPS beats by $0.06, beats on r... | 11/06/20 |
| ImmunoGen (NASDAQ:IMGN): Q3 GAAP EPS of -$0.13 beats by $0.06. Revenue of $18.19M (+37.0% Y/Y) beats by $2.96M. The company has updated its financial ... | |
| ImmunoGen Reports Recent Progress and Th... | 11/06/20 |
| WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Reports Recent Progress and Third Quarter 2020 Financial Results | |
| Earnings Outlook for Immunogen | 11/05/20 |
| On Friday, November 06, Immunogen (NASDAQ: IMGN) will release its latest earnings report. Benzinga's outlook for Immunogen is included in the ??? | |
| ImmunoGen Announces Webcast of Presentat... | 11/04/20 |
| WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Webcast of Presentation at Upcoming Jefferies Virtual London Healthcare Conference | |
| FXNEWS24 |Earnings Preview: ImmunoGen (I... | 10/30/20 |
| Earnings Preview: ImmunoGen (IMGN) Q3 Earnings Expected to Decline | UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News | |
| ImmunoGen (NASDAQ:IMGN) Stock Price Up 5... | 10/24/20 |
| ImmunoGen, Inc. (NASDAQ:IMGN) shares were up 5.2% during mid-day trading on Thursday . The stock traded as high as $5.53 and last traded at $5.50. App... | |
| ImmunoGen Announces Conference Call to D... | 10/22/20 |
| WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2020 Operating Results | |
| Canaccord Genuity Reiterates Buy Rating ... | 10/21/20 |
| ImmunoGen (NASDAQ:IMGN)???s stock had its ???buy??? rating reaffirmed by equities researchers at Canaccord Genuity in a report issued on Tuesday, Anal... | |
| ImmunoGen (NASDAQ:IMGN) Earns ???Buy??? ... | 10/20/20 |
| Canaccord Genuity reiterated their buy rating on shares of ImmunoGen (NASDAQ:IMGN) in a research report report published on Tuesday morning, AnalystRa... | |
| ImmunoGen (NASDAQ:IMGN) Shares Down 7.1% | 10/20/20 |
| Shares of ImmunoGen, Inc. (NASDAQ:IMGN) traded down 7.1% on Tuesday . The stock traded as low as $5.03 and last traded at $5.25. 4,518,495 shares trad... | |
| ImmunoGen (NASDAQ:IMGN) Stock Rating Rea... | 10/20/20 |
| ImmunoGen (NASDAQ:IMGN)???s stock had its ???buy??? rating reiterated by Canaccord Genuity in a research report issued to clients and investors on Tue... | |
| Antibody Drug Conjugate Market, Top key ... | 10/12/20 |
| Antibody Drug Conjugate Market Size, Status and Forecast 2026 The Antibody Drug Conjugate Market Research Report is a valuable source of insightful da... | |
| ImmunoGen Raises $54.8 Million in Gross ... | 10/12/20 |
| WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Raises $54.8 Million in Gross Proceeds Through its At-the-Market Facility | |
| ImmunoGen Soars 14% On FDA Breakthrough ... | 10/06/20 |
| Shares of ImmunoGen spiked 14.2% on Monday after the biotechnology company said that the U. The post ImmunoGen Soars 14% On FDA Breakthrough Designati... | |
| ImmunoGen Announces FDA Breakthrough The... | 10/05/20 |
| WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces FDA Breakthrough Therapy Designation for IMGN632 in Relapsed or Refractory Blastic Plasmacytoid D... | |
| ImmunoGen Presents Final Data From Phase... | 09/17/20 |
| ImmunoGen Presents Final Data from Phase 1b FORWARD II Triplet Cohort Evaluating Mirvetuximab in Combination with Carboplatin and Avastin?? at ESMO | |
| ImmunoGen Announces Webcast of Presentat... | 09/02/20 |
| WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Webcast of Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference | |
| Warner Music acquires Israeli start-up I... | 08/18/20 |
| Tel Aviv and New York-based IMGN will continue to act as its own entity, helping Warner to build and track content on social media. | |
| Warner Music : IMGN Media Acquired by Wa... | 08/14/20 |
| Today it was announced that digital media company IMGN Media has been acquired by Warner Music Group. Founded in 2015, and headquartered in New York a... | |
| ImmunoGen Announces Inducement Grants Un... | 08/03/20 |
| WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | |
| ImmunoGen (IMGN) Earnings: 2Q20 Key Numb... | 07/31/20 |
| ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today. Revenues were $15 million, compared to $15.5 million in the prior-y... | |
| ImmunoGen Reports Recent Progress and Se... | 07/31/20 |
| ImmunoGen Reports Recent Progress and Second Quarter 2020 Financial Results | |
| ImmunoGen Announces Webcast of Presentat... | 07/29/20 |
| WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Webcast of Presentation at Upcoming Canaccord Genuity Virtual Growth Conference | |
| ImmunoGen Appoints Susan Altschuller, Ph... | 07/20/20 |
| ImmunoGen Appoints Susan Altschuller, PhD as Senior Vice President and Chief Financial Officer | |
| ImmunoGen Announces Conference Call to D... | 07/16/20 |
| WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2020 Operating Results | |
| Buy rating | 11/06/20 |
| SVB Leerink maintains Market Perform rating and raises Price Target from $5.00 to $6.00 | |
| Date | 2020-11-06 (BMO) | Est. (EPS/Rev.) | ($0.18)/ 15.36M |
| Actual (EPS/Rev.) | $-0.13/ $18.19 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| AND I WONDER | JOHN KROLIKOWSKI JR | 91.00 % | Follow |
| FEAT. ANDRE 3000 | JOHN KROLIKOWSKI JR | 90.00 % | Subscribe |
| WIDE AWAKE | JOHN KROLIKOWSKI JR | 81.00 % | Follow |
| Option Attack | James Callyway | 61.00 % | Subscribe |
| Burdeshaw Investing | Matthew Burdeshaw | 55.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
